Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Saving in your 20s is vital for long-term financial stability. Discover the key reasons to prioritize saving at this age.
21,735 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A fresh look at how to read Lifetime Brands' Q4 2025 earnings transcript. This guide explains key metrics, growth dri...
A reader invites a friend to act as an informal adviser, only to learn the friend is paid to push certain funds. The ...
NVIDIA Just Surpassed Silver marks a seismic moment in asset valuation. This story breaks down what’s driving the sur...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
SanDisk stock soared today as investors weighed memory-chip demand, rival earnings, and risk factors. This guide brea...
Nike stock has fallen significantly from its 52-week peak, even as the CEO buys shares. This guide explains what the ...
Senate Democrats allege the White House granted tariff exemptions to firms tied to donors, sparking a bipartisan push...
In today’s Morning Minute, Circle earnings take center stage as crypto markets rally. Stablecoins anchor liquidity wh...
A fresh, practical look at Marek Capital’s investment playbook. Discover how MiB: Matt Cherwin, Co-Founder and CIO, s...
A corporate insider sold a meaningful chunk of stock after a record revenue year. This article breaks down what such ...
AI-driven tech stocks swing in early 2026 as valuations recalibrate. Analysts say a consumer staples ETF can help hed...